Healthscope Limited (HSP) - Financial and Strategic Analysis Review by GlobalData

VIEWS: 68 PAGES: 31

More Info
									          Healthscope Limited (HSP) - Financial and Strategic Analysis Review

       Reference Code: GDPH29934FSA                                                                                   Publication Date: JUL 2010

       Level 1, 407 Royal Parade         Phone           +61 3 93567500                            Revenue           1,657 (million AUD)
       Parkville, VIC                    Fax             +61 3 93567599                            Net Profit        72.29 (million AUD)
       3052                              Website         www.healthscope.com.au                    Employees         16,549
       Australia                         Exchange        HSP [Australian Stock Exchange]           Industry          Pharmaceuticals & Healthcare

      Company Overview
       Healthscope Limited (Healthscope) is an Australian healthcare company that offers healthcare services to its customers through
       the management of hospitals and medical centers. The company operates through two business segments: Hospitals Segment
       and Pathology Segment. Its Hospitals segment manages surgical and non-surgical private hospitals, while its Pathology segment
       offers pathology services to the customers. Also, the company has medical centres division, through which it operates 45 clinics
       and a diagnostic imaging division. Healthscope operates facilities in New Zealand, Australia and South East Asia.

      Key Executives                                                            SWOT Analysis
                    Name                                  Title                 Healthscope Limited, SWOT Analysis
      Bruce R. Dixon                       Director                             Strengths                  Weaknesses

      Linda B. Nicholls AO                 Chairman
                                                                                Consistent Revenue Growth           Increasing Operating
      Richard A.F. England                 Director                                                                 Expenses
      Ziggy E. Switkowski, Ph.D.           Director                             Aggressive Acquisition
                                                                                Strategy                            Highly Leveraged
      Philip Bullock                       Director
      Source: Annual Report, Company Website, Primary and Secondary Research
      GlobalData
                                                                                Opportunities                       Threats
      Share Data
       Healthscope Limited                                                      Hospital Redevelopment              Rapid Technology
       Share Price (AUD) as on 20-Jul-2010                               5.90   Programs                            Advancements

       EPS (AUD)                                                         0.29
                                                                                Agreement with Polartechnics        Changing Government
       Market Cap (million AUD)                                        1,525                                        Regulations
       Enterprise Value (million AUD)                                  2,202

       Shares Outstanding (million)                                       257
       Source: Annual Report, Company Website, Primary and Secondary Research  
								
To top